default author photo

Kuan Peng

The University of Hong Kong - Centre for Safe Medication Practice and Research

SCHOLARLY PAPERS

2

DOWNLOADS

175

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Self-Reported Reactogenicity of CoronaVac (Sinovac) Compared with Comirnaty (Pfizer-BioNTech): A Prospective Cohort Study with Intensive Monitoring

Number of pages: 16 Posted: 13 Nov 2021
The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, Hong Kong Science and Technology Park - Laboratory of Data Discovery for Health (D24H), The University of Hong Kong, The University of Hong Kong - Department of Family Medicine and Primary Care, Hong Kong Special Administration Region Government - Department of Health, Hong Kong Special Administration Region Government - Department of Health, The University of Hong Kong - WHO Collaborating Centre for Infectious Disease Epidemiology and Control, The University of Hong Kong - Centre for Safe Medication Practice and Research and The University of Hong Kong - Centre for Safe Medication Practice and Research
Downloads 96 (715,072)

Abstract:

Loading...

Community vaccination center, Covid-19, Pain, SARS-CoV-2, Self-reported adverse reactions, Severe allergic reactions, Systemic reactions

2.

Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis

Number of pages: 40 Posted: 12 Jul 2022
The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Centre for Safe Medication Practice and Research, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of Cincinnati - Department of Pharmacy, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, National Cheng Kung University - Institute of Clinical Pharmacy and Pharmaceutical Sciences, Sungkyunkwan University - Department of Biohealth Regulatory Science, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Department of Medicine, Tianjin University - School of Pharmaceutical Science and Technology, The University of Hong Kong - Queen Mary Hospital, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Centre for Safe Medication Practice and Research and The University of Hong Kong - Centre for Safe Medication Practice and Research
Downloads 79 (844,901)
Citation 1

Abstract:

Loading...

Biosimilar, Interrupted Time-Series Analysis, Quasi experiment, Infliximab, Consumption, Listed Price, Drug policy, Economics